BreStem Therapeutics, Inc. — Form D
BreStem Therapeutics, Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-06. The offering totals $2.0M, of which $250K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-07-06
- Form: D
- Accession: 0001723963-21-000004
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $250K
- Remaining: $1.8M
- Investors: 1
- Date of first sale: 2021-06-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405341
Issuer
- Name: BreStem Therapeutics, Inc.
- CIK: 0001723963
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2017
- Address: 1001 WILLIAM MOORE DRIVE, RALEIGH, NC, 27606
- Phone: 919-513-6157
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Weili Zhou | Director | RALEIGH, NC |
| Weigang Wang | Director | RALEIGH, NC |
| Ke Cheng | Director | RALEIGH, NC |
| Ke Cheng | Executive Officer | RALEIGH, NC |
| Dongmei Zhu | Executive Officer | Raleigh, NC |
Other filings by this issuer (2)
More